(Q35743851)

10 August 2017

Manipulating angiogenesis in medicine (English)

1 reference

10 August 2017

1 reference

1

Peter Carmeliet

1 reference

PubMed ID

15078497

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Journal of Internal Medicine

10 August 2017

1 reference

10 August 2017

255

1 reference

10 August 2017

538-561

1 reference

10 August 2017

5

1 reference

Clinical translation of angiogenesis inhibitors

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Adipose tissue mass can be regulated through the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Aging and survival of cutaneous microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: role of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The hemangioblast: a common progenitor of hematopoietic and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The search for the hemangioblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

A role for hematopoietic stem cells in promoting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The SCL gene specifies haemangioblast development from early mesoderm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The role of FGF and VEGF in angioblast induction and migration during vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Origin of endothelial progenitors in human postnatal bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Common origins of blood and blood vessels in adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Smooth muscle cell origin and its relation to heterogeneity in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Role of cardiac neural crest cells in cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Common epicardial origin of coronary vascular smooth muscle, perivascular fibroblasts, and intermyocardial fibroblasts in the avian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Smooth muscle progenitor cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

An address system in the vasculature of normal tissues and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Diversity within pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Insights into early vasculogenesis revealed by expression of the ETS-domain transcription factor Fli-1 in wild-type and mutant zebrafish embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Developmental biology. Controlling the cellular brakes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Specialization of tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Gridlock signalling pathway fashions the first embryonic artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

A role for notochord in axial vascular development revealed by analysis of phenotype and the expression of VEGR-2 in zebrafish flh and ntl mutant embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vessel patterning in the embryo of the zebrafish: guidance by notochord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Radar is required for the establishment of vascular integrity in the zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Induction of embryonic hematopoietic and endothelial stem/progenitor cells by hedgehog-mediated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Arterial identity of endothelial cells is controlled by local cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Arteries and veins: making a difference with zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

gridlock, an HLH gene required for assembly of the aorta in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Notch signaling in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Regulation of angiogenesis by hypoxia: role of the HIF system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Unorthodox angiogenesis in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Optimality in the developing vascular system: branching remodeling by means of intussusception as an efficient adaptation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

VEGF: a modifier of the del22q11 (DiGeorge) syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Inhibition of angiogenesis by a mouse sprouty protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Chromosomal microdeletions: dissecting del22q11 syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular endothelial growth factor as a target opportunity in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vaccination against tumor neovascularization: Promise and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Expression of vascular endothelial growth factor receptors in smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Monoclonal antibodies to vascular endothelial growth factor (VEGF) and the VEGF receptor, FLT-1, inhibit the growth of C6 glioma in a mouse xenograft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

A reevaluation of integrins as regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Matrix metalloproteinases and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Kallistatin is a new inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Developmental biology. One cell, two fates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Analysis of mural cell recruitment to tumor vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Hemangiomas: evaluation and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

PDGF-D is a potent transforming and angiogenic growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Direct cell adhesion to the angiopoietins mediated by integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Down-regulation of angiopoietin-1 expression in menorrhagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin-2 plays an important role in retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Genetics of pulmonary hypertension: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Signaling molecules in nonfamilial pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Analysis of the role of chemokines in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiopoietin-1 Protects Against the Development of Cardiac Allograft Arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Platelets and cancer: implications for antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Tissue factor and angiogenesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3alpha locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Blood monocyte concentration is critical for enhancement of collateral artery growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

21 January 2018

Myocardial gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

Identification of an angiogenic mitogen selective for endocrine gland endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2003.01297.X

10.1111/J.1365-2796.2003.01297.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15078497